urticarial rash on face and neck; this is a spontaneous report received from a contactable reporter(s) (physician) from the regulatory authority-web. regulatory number: gr-greof-202200456 (regulatory authority). a 15-year-old female patient received bnt162b2 (comirnaty), administration date 18jan2022 (lot number: unknown) at the age of 15 years as dose 2, single for covid-19 immunisation. relevant medical history included: "allergy" (ongoing). the patient's concomitant medications were not reported. vaccination history included: covid-19 vaccine (dose 1; manufactuerer unknown), for covid-19 immunisation. the following information was reported: urticaria (hospitalization, medically significant) with onset 18jan2022, outcome "recovering", described as "urticarial rash on face and neck". the clinical course was reported as follows: after vaccination she presented with urticarial rash on face and neck. due to history of allergies, she received zirtec 10 mg after vaccination and before the manifestation of the adverse reaction. after the initiation of the symptom and 11 hours after vaccination she received again zirtec 10 mg per os (oral) and hydrocortisone 250 mg intravenously. she was hospitalised precautionary and took discharge the next day in an improved condition. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected